December is the month for both tax loss selling and tax gain selling. WG has been so volatile that many WG holders bought substantially above or substantially below present prices. This tax-driven selling lowers the price of the sold stocks, often to bargain levels. The price then recovers in January, and contributes to the "January effect." So December is a good month to buy stock or calls, or to sell puts. I think this applies to WG, very strongly.
When I am annoyingly underwater on a stock I vote against every director and against every payment to directors and executives. I especially dislike new stock options after a stock has fallen; there should be no reward for correcting poor performance to mediocre.
The price drop today persuaded me to make my first purchase of SN. I suppose that emotional reactions to the WSJ article caused the price drop, amplified by daytrading shorts.
The WSJ article did NOT say that SN overpaid for the leases. Independent parties examined the lease offers and judged them fair before the lease agreement was made. The article said there was controversy. No wrongdoing was established.
I noticed that AIG has been expecting to sell an aircraft leasing division to a Chinese company or companies, but new deadlines for closing keep coming and going and the deal is not done. From another perspective Concord Medical CCM a Chinese medical services company announced a stock sale at a price substantially higher than it has been trading for on the open market, with an implication of a possible buyout. However, no buyout offer actually appeared. It seems that suggesting a buyout is a peculiar (and unreliable) negotiation method used by Chinese companies. What they are negotiating for is not clear to us the public, of course.
This "buyout value" is only an estimate and is if the buyout took place today. It is based on the assumption that the value of the buyout was $17.83 when the CACB price was $5.96, as stated by Globewire news. The point of making the calculation is that the buyout value fluctuates with CACB share price. CACB share price has been much higher in the past.
Huge media attention to unusually high risk patients is undeserved. If MDT has to study extreme high risk patients to show an advantage for their valve, their case is weak. Expected advantages if any should be undetectable in usual patients, who are less ill; that is, the vast majority of patients. With these patients MDs familiarity with Edwards' valve should make it the preferred valve. I wrote this comment at the bottom of the Motley Fool piece that was inappropriately critical of Edwards but they would not post it; that is disgraceful.
$0.035 I guess.
However, tax loss selling season just started. MNDO's price has fallen progressively throughout 2013, so stockholders who bought MNDO during 2013 but have capital gains from other stocks may be tempted to sell MNDO. That is, if they don't own JCP or gold miners.
MNDO earned $0.03/share for first half 2013, so the likely range for the last half 2013 is $0.03 to $0.07. The corresponding dividend range is $0.06 to $0.10 for the year. Sure it could be higher or lower, but I'm just considering likelihood. MNDO is susceptible to pump-and-dumpers because of the light trading volume,
You are right. I misled myself. The buyout price is valued in the 17s. There is a lucrative arbitrage opportunity here now IMO.
The same law firms are filing lawsuits against McDermott (MDR) and Edwards Lifesciences (EW), and surely others. These lawsuits are all about the law firms themselves and nothing else. By accepting a weak buyout offer HOME management admitted that it is weak. It is so weak that BANR said the aquisition is immediately accretive. There is room for another buyer to outbid BANR.
The news report is below. However, an offer of 6.31 Euros makes no sense because (according to Yahoo) each share corresponds to $11.40 cash and no debt. Moreover, $8.50 shares are at 2/3 of book value, so book value is about $12.75. Selling under $11.40 is simply giving away cash.
Avic International Holdings Ltd. (161), a Hong Kong-listed unit of China’s biggest aerospace company, said it will boost its holding in German industrial-plant builder KHD Humboldt Wedag International AG (KWG) and make a buyout offer.
The Shenzhen, China-based company will buy 19 percent of KHD from 12 sellers for 61 million euros ($83 million), increasing its stake to 39 percent, according to a Hong Kong stock exchange filing yesterday. MFC Industrial Ltd. is one of the companies disposing of KHD shares.
Avic also said it will join companies owned by Singaporean businessman Yap Lian Seng to make an offer for KHD at 6.45 euros a share, or a total consideration of 195.5 million euros. Yap will own 58 percent of KHD and Avic 42 percent if all holders accept the offer.
KHD jumped 24 percent to close at 6.31 euros on Frankfurt’s Xetra exchange after the offer was announced.
The trading base is the Open House Clientele, at least for now. They aim to earn $99 back.
The deal's aroma is attracting flies.
I found nine law firms that issued press releases describing intention to investigate, and apparent hopes to sue. Wriing a message on a discussion board is not a press release.
The nine are (in no particular order):
We have started to enter TwitterStockMania. Next week it will be in our faces.
The 20- and 50-day EMA are well below the 200-day EMA, and they are pointing down. You don't need to be a chart technician to see that this year is different from previous years in this regard.